Interaction Checker

Add peptides or compounds to check all pairwise interactions, cumulative organ load, and safety flags.

This stack requires monitoring: 0 interaction(s) need attention. No critical conflicts, but bloodwork and regular check-ins recommended.
Elevated gonads load from Anastrozole, MENT. Monitor this organ system closely.

Cumulative Organ Load

Gonads
elevated
Heart
moderate
Liver
moderate
Pituitary
low

Shared Safety Flags

2x 2 androgenic compounds (Anastrozole, MENT). Additive androgenic load — increased risk of hair loss, acne, prostate effects.
2x 2 compounds share the aromatase-inhibitor safety flag (Anastrozole, MENT). Monitor accordingly.
2x 2 estrogenic compounds (Anastrozole, MENT). Combined estrogen elevation — monitor E2 and consider aromatase inhibitor.
2x 2 HPTA-suppressive compounds (Anastrozole, MENT). Deep hormonal shutdown expected — plan extended PCT.
2x 2 compounds disrupt lipids (Anastrozole, MENT). Get lipid panel mid-cycle — consider adding lipid support.
2x 2 compounds share the teratogenic safety flag (Anastrozole, MENT). Monitor accordingly.
+
Anastrozole + MENT
Compatible

Aromatase inhibitors have reduced efficacy with MENT because its aromatization product, 7-alpha-methyl-estradiol, is a methylated estrogen that is less effectively blocked by conventional AIs. Anastrozole will still provide some estrogen control but typically not as complete as when managing estrogen from testosterone. Users may need higher AI doses than expected, and some find AIs insufficient at higher MENT doses. Monitor symptoms and bloodwork closely -- standard estradiol assays may not fully capture 7-alpha-methyl-estradiol levels.

Researched 90% confidence Compare

Interaction data is compiled from research literature, pharmacological analysis, and community reports. Inferred interactions are based on known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.